TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33464758

Group type: EXPERIMENTAL
Intervention: HSK3486
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32615488

Group type: EXPERIMENTAL
Intervention: 5 g lyophilized juçara for 6 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (no juçara supplementation)
Number of subjects: 35
Study: 36469315

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced CT-based radiomics
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Logistic regression model based on selected radiomic features
Number of subjects: 665
Study: 33845035

Group type: EXPERIMENTAL
Intervention: 21 Gy intraoperative radiotherapy with electrons (ELIOT) in a single dose to the tumour bed during surgery
Number of subjects: 1305

Group type: COMPARATOR
Intervention: Whole-breast irradiation (WBI) with conventional fractionation (50 Gy given as 25 fractions of 2 Gy, plus a 10 Gy boost)
Number of subjects: 1305

Group type: EXPERIMENTAL
Intervention: Overall survival in ELIOT group
Number of subjects: 1305

Group type: COMPARATOR
Intervention: Overall survival in WBI group
Number of subjects: 1305
Study: 35147825

Group type: EXPERIMENTAL
Intervention: Mothers Supporting the Emotional Development of Their Children program (intervention)
Number of subjects: 122

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 122
Study: 33289961

Group type: EXPERIMENTAL
Intervention: Abstinence goals
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Reduced use goals
Number of subjects: 39
Study: 36308305

Group type: EXPERIMENTAL
Intervention: Tablet app-based program (n=26)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control strengthening exercise program (n=22)
Number of subjects: 48
Study: 33676538

Group type: EXPERIMENTAL
Intervention: ActWELL intervention (personalised diet advice and pedometer walking plans)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Comparison group (usual care)
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: ActWELL intervention
Number of subjects: 560
Study: 32615994

Group type: EXPERIMENTAL
Intervention: Inhaled granulocyte-macrophage colony stimulating factor (GM-CSF) for 6 months
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 36229900

Group type: EXPERIMENTAL
Intervention: LID group (41 patients)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No-LID group (34 patients)
Number of subjects: 75
Study: 32959232

Group type: EXPERIMENTAL
Intervention: Preoperative blood glucose to lymphocyte ratio with an optimal cutoff value of 3.47 for overall survival.
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Younger male patients with pancreatic body and tail cancer, AJCC 8th N1 stage, without microvascular and peripancreatic fat invasion, CA 19-9 > 200 U/ml.
Number of subjects: 259
Study: 32946355

Group type: EXPERIMENTAL
Intervention: Consolidation radiotherapy (cRT) with a median dose of 30.6 Gy (range, 24-36 Gy)
Number of subjects: 296

Group type: COMPARATOR
Intervention: No further treatment (NFT)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Consolidation radiotherapy (cRT)
Number of subjects: 296
Study: 34915329

Group type: EXPERIMENTAL
Intervention: Topical capsaicin
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 33245972

Group type: EXPERIMENTAL
Intervention: Single cone with BC 150 Series Gutta‐Percha Points and EndoSequence BC Sealer (SC2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Continuous wave with EndoSequence Gutta‐Percha Points and Ribbon Sealer (CW)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cold lateral condensation with EndoSequence Gutta‐Percha Points and Ribbon Sealer (CL)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Single cone with EndoSequence Gutta‐Percha Points and Ribbon Sealer (SC1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: GuttaCore carrier obturation (GC)
Number of subjects: 50
Study: 35134951

Group type: EXPERIMENTAL
Intervention: Rotarix
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study: 34802039

Group type: EXPERIMENTAL
Intervention: Celecoxib combined with risperidone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo combined with risperidone
Number of subjects: 100
Study: 34371176

Group type: EXPERIMENTAL
Intervention: Percutaneous biliary drainage (PTD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Endoscopic stenting (ERCP)
Number of subjects: 60
Study: 32452275

Group type: EXPERIMENTAL
Intervention: Wearable device (WD) with shock paired 12 ms before click
Number of subjects: 95

Group type: COMPARATOR
Intervention: Wearable device (WD) with clicks and shocks delivered independently
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 95
Study: 36380284

Group type: EXPERIMENTAL
Intervention: Erenumab (70 or 140 mg/month)
Number of subjects: 777

Group type: COMPARATOR
Intervention: Topiramate (50-100 mg/day)
Number of subjects: 777
Study: 32000261

Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 362

Group type: COMPARATOR
Intervention: Muscular strength and speed/agility
Number of subjects: 362
Study: 35604416

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 33951374

Group type: EXPERIMENTAL
Intervention: NVX-CoV2373 vaccine (5 µg of recombinant spike protein with 50 µg of Matrix-M1 adjuvant)
Number of subjects: 4387

Group type: EXPERIMENTAL
Intervention: NVX-CoV2373 vaccine
Number of subjects: 4387

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4387
Study: 32017932

Group type: EXPERIMENTAL
Intervention: Luminal plugging in COPD subjects
Number of subjects: 500

Group type: COMPARATOR
Intervention: Luminal plugging in non-COPD smokers
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Chronic bronchitis in COPD subjects
Number of subjects: 500
Study: 36327545

Group type: EXPERIMENTAL
Intervention: Multidirectional elastic tape
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control tape
Number of subjects: 27
Study: 35142815

Group type: EXPERIMENTAL
Intervention: DCVAC/PCa plus docetaxel and prednisone
Number of subjects: 1182

Group type: COMPARATOR
Intervention: Placebo plus docetaxel and prednisone
Number of subjects: 1182

Group type: EXPERIMENTAL
Intervention: DCVAC/PCa
Number of subjects: 1182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1182
Study: 35276780

Group type: EXPERIMENTAL
Intervention: High-Carbohydrate/Low Fat diet (HC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate diet (LC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (6 participants)
Number of subjects: 24
Study: 33305526

Group type: COMPARATOR
Intervention: Continuous energy restriction (CONT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Intermittent energy restriction (IER)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both CONT and IER
Number of subjects: 35
Study: 35768939

Group type: EXPERIMENTAL
Intervention: Early Start (ES)
Number of subjects: 208
Study: 33443609

Group type: EXPERIMENTAL
Intervention: Testosterone treatment (TT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Testosterone treatment (TT) combined with resistance training (TT + RT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Testosterone treatment (TT + RT)
Number of subjects: 20
Study: 33043836

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (EX)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 27
Study: 35288147

Group type: EXPERIMENTAL
Intervention: Cold snaring
Number of subjects: 235

Group type: COMPARATOR
Intervention: Hot EMR
Number of subjects: 235

Group type: COMPARATOR
Intervention: Hot snare
Number of subjects: 235

Group type: COMPARATOR
Intervention: Cold EMR
Number of subjects: 235
Study: 33010091

Group type: EXPERIMENTAL
Intervention: Printed brochures focused on rural men affected by cancer
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Printed brochures focused on rural location only
Number of subjects: 114

Group type: COMPARATOR
Intervention: Generic cancer support material
Number of subjects: 114
Study: 33188612

Group type: EXPERIMENTAL
Intervention: Decision Aid (DA)
Number of subjects: 240
Study: 33328728

Group type: EXPERIMENTAL
Intervention: Nopal cactus fruit juice (NFJ) 3 oz/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 35977107

Group type: EXPERIMENTAL
Intervention: High calcium meal (CAL; 1000 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Isocaloric low calcium meal (CON; <10 mg)
Number of subjects: 16
Study: 34620664

Group type: EXPERIMENTAL
Intervention: everolimus with reduced-exposure calcineurin inhibitor (EVR+rCNI)
Number of subjects: 2037

Group type: COMPARATOR
Intervention: mycophenolic acid with standard-exposure CNI (MPA+sCNI)
Number of subjects: 2037
Study: 36173425

Group type: EXPERIMENTAL
Intervention: Active fronto-motor tACS
Number of subjects: 74

Group type: COMPARATOR
Intervention: Sham tACS
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control montage tACS
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Motor training
Number of subjects: 74
Study: 33454584

Group type: EXPERIMENTAL
Intervention: Ozanimod 0.92 mg
Number of subjects: 1346

Group type: COMPARATOR
Intervention: Interferon β‐1a
Number of subjects: 1346
Study: 35901768

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: IV r‐tPA and EVT
Number of subjects: 0
Study: 33992274

Group type: EXPERIMENTAL
Intervention: Vojta group (A)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard therapy group (B)
Number of subjects: 21
Study: 32520773

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35580836

Group type: EXPERIMENTAL
Intervention: Abbreviated dual antiplatelet therapy (DAPT)
Number of subjects: 2816

Group type: COMPARATOR
Intervention: Standard dual antiplatelet therapy (DAPT)
Number of subjects: 2816
Study: 33076878

Group type: EXPERIMENTAL
Intervention: Biokesum® (Persicaria minor extract), 250 mg/capsule, twice daily for 6 months
Number of subjects: 36
Study: 34551124

Group type: EXPERIMENTAL
Intervention: 300 IR HDM tablet (sublingual allergen immunotherapy)
Number of subjects: 0
Study: 34280646

Group type: COMPARATOR
Intervention: Conventional strains (CONV; strains B and C: ADG0‐48 > 60 g/d)
Number of subjects: 7216

Group type: EXPERIMENTAL
Intervention: Slower-growing strains (SL; categorized as FAST, MOD, SLOW)
Number of subjects: 7216

Group type: EXPERIMENTAL
Intervention: Strain F (FAST category)
Number of subjects: 7216

Group type: COMPARATOR
Intervention: Conventional strains (CONV) at TW 2
Number of subjects: 7216

Group type: EXPERIMENTAL
Intervention: Strain F (FAST category) at both TWs
Number of subjects: 7216
Study: 34073684

Group type: EXPERIMENTAL
Intervention: Probiotic group (PG; n = 15) received a drink containing Lactobacillus casei Shirota (3 × 10^10 CFU)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo group (CG; n = 15) received a placebo drink
Number of subjects: 30
Study: 33186192

Group type: EXPERIMENTAL
Intervention: Office-based vergence/accommodative therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Office-based placebo therapy
Number of subjects: 50
Study: 33805664

Group type: EXPERIMENTAL
Intervention: Psychoeducational group intervention (12 weekly sessions of 90 min)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Standard care (Control Group)
Number of subjects: 380
Study: 33368978

Group type: EXPERIMENTAL
Intervention: Enhanced video
Number of subjects: 54

Group type: COMPARATOR
Intervention: Non-enhanced video
Number of subjects: 54
Study: 33033007

Group type: EXPERIMENTAL
Intervention: Behavioural intervention for HIV knowledge
Number of subjects: 662
Study: 34003449

Group type: EXPERIMENTAL
Intervention: Postoperative 5th month
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative 5th month
Number of subjects: 50
Study: 34170910

Group type: EXPERIMENTAL
Intervention: Preventive practices (wearing facemask, frequent hand washing)
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Perceived risk of COVID-19
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Perceived risk to family
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Worry score about COVID-19 crisis
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Worry about health system overwhelmed
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Worry about health of loved ones
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Worry about losing someone due to COVID-19
Number of subjects: 1134

Group type: COMPARATOR
Intervention: Previous clinical care experience
Number of subjects: 1134
Study: 32813737

Group type: EXPERIMENTAL
Intervention: Dense BGN
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MBGN
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dense BGN and MBGN
Number of subjects: 24
Study: 35172592

Group type: EXPERIMENTAL
Intervention: IPS+VR‐JIT
Number of subjects: 90

Group type: COMPARATOR
Intervention: IPS as usual
Number of subjects: 90
Study: 33096965

Group type: EXPERIMENTAL
Intervention: Moderate intensity-interval-training exercise with blood flow restriction (BFR) and body cooling (BC)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Exercise without blood flow restriction (BFR) and body cooling (BC)
Number of subjects: 25
Study: 32700009

Group type: COMPARATOR
Intervention: Nonabsorbable sutures (6/0 polypropylene)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Absorbable sutures (6/0 polyglytone 6211)
Number of subjects: 64
Study: 33009239

Group type: EXPERIMENTAL
Intervention: Short stem (n = 56)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard stem (n = 44)
Number of subjects: 100
Study: 32000509

Group type: EXPERIMENTAL
Intervention: Attachment and Child Health intervention (randomized controlled trial)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Attachment and Child Health intervention (quasi-experimental study)
Number of subjects: 30
Study: 36194220

Group type: EXPERIMENTAL
Intervention: Telmisartan plus exercise
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Telmisartan plus attention control
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo plus exercise
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo plus attention control
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 34695957

Group type: EXPERIMENTAL
Intervention: S2 prototype (interactive grasp rehabilitation system)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 26
Study: 33355155

Group type: EXPERIMENTAL
Intervention: Burn 2 Learn (B2L) intervention
Number of subjects: 670

Group type: COMPARATOR
Intervention: Control group (usual practice)
Number of subjects: 670
Study: 36361335

Group type: EXPERIMENTAL
Intervention: Exercise (60 min sessions, 3 days/week, from the 17th gestational week until birth)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Higher consumption of fruits
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Lower intake of red meat and subproducts
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Greater Mediterranean diet adherence
Number of subjects: 85
Study: 33863326

Group type: EXPERIMENTAL
Intervention: Integrated eDiagnosis Approach (IeDA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (standard IMCI)
Number of subjects: 10
Study: 35109752

Group type: EXPERIMENTAL
Intervention: Dry needling (DN) of thenar muscles TrP(s)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 30
Study: 33465135

Group type: EXPERIMENTAL
Intervention: Fibrinolytic therapy
Number of subjects: 9508

Group type: EXPERIMENTAL
Intervention: Successful fibrinolysis
Number of subjects: 9508

Group type: EXPERIMENTAL
Intervention: Unsuccessful fibrinolysis
Number of subjects: 9508

Group type: COMPARATOR
Intervention: CKD status
Number of subjects: 9508
Study: 32843171

Group type: EXPERIMENTAL
Intervention: High altitude rehabilitation (HA, 3100 m)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low altitude rehabilitation (LA, 760 m)
Number of subjects: 50
Study: 35147680

Group type: EXPERIMENTAL
Intervention: AmBisome monotherapy (40 mg/kg intravenous liposomal amphotericin B administered in 8 equal doses over 24 days)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combination therapy (30 mg/kg intravenous AmBisome administered in 6 equal doses over 24 days + 1.4 g oral miltefosine administered in 2 daily doses of 50 mg over 14 days)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: AmBisome monotherapy (excluding those with concurrent tuberculosis)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combination therapy (excluding those with concurrent tuberculosis)
Number of subjects: 150
Study: 33446902

Group type: EXPERIMENTAL
Intervention: 3-5 sessions of ALSS therapy
Number of subjects: 601

Group type: COMPARATOR
Intervention: 1-2 sessions of ALSS therapy
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: ≥6 sessions of ALSS therapy
Number of subjects: 601

Group type: COMPARATOR
Intervention: ≤2 sessions of ALSS therapy
Number of subjects: 601
Study: 32841256

Group type: EXPERIMENTAL
Intervention: Micronutrient supplement
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study: 34059932

Group type: EXPERIMENTAL
Intervention: pirenzepine 75 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: vonoprazan 10 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: vonoprazan 10 mg plus pirenzepine 75 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: vonoprazan 10 mg alone (control)
Number of subjects: 11
Study: 35219331

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily for 12 weeks
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 32192515

Group type: EXPERIMENTAL
Intervention: Family Integrated Care (FICare)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34043794

Group type: EXPERIMENTAL
Intervention: Dual hormone clamp (cortisol and testosterone fixed)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Matching placebo (cortisol and testosterone not fixed)
Number of subjects: 34
Study: 33068901

Group type: EXPERIMENTAL
Intervention: 6-week group exercise and self-management intervention facilitated by a physiotherapist
Number of subjects: 349

Group type: COMPARATOR
Intervention: Continued GP management
Number of subjects: 349
Study: 34473247

Group type: EXPERIMENTAL
Intervention: Higher levels of familism in African American and Hispanic participants compared to Whites.
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Greater levels of social support in African Americans compared to Whites.
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Exploratory analyses of familism and self-efficacy.
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Familism in the Hispanic subgroup.
Number of subjects: 243
Study: 34704984

Group type: EXPERIMENTAL
Intervention: 2g amoxicillin 1 hour prior to surgery
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 33327134

Group type: EXPERIMENTAL
Intervention: Ordinal network algorithm for mapping images into networks
Number of subjects: 0
Study: 33091856

Group type: EXPERIMENTAL
Intervention: Cinnamon Patch (CP)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 34031921

Group type: EXPERIMENTAL
Intervention: Implantoplasty with cyclic loading
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-instrumented controls
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All implants (instrumented and non-instrumented)
Number of subjects: 30
Study: 32238855

Group type: EXPERIMENTAL
Intervention: Transnasal humidified rapid insufflation ventilatory exchange (THRIVE) with 100% oxygen at 30-70 litres/min
Number of subjects: 60

Group type: COMPARATOR
Intervention: Facemask oxygenation with 100% oxygen at 10 litres/min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: THRIVE
Number of subjects: 60

Group type: COMPARATOR
Intervention: THRIVE and facemask
Number of subjects: 60
Study: 35689170

Group type: EXPERIMENTAL
Intervention: Om chanting and Yoga Nidra for five days a week for two months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Regular conventional medications
Number of subjects: 80
Study: 34144104

Group type: EXPERIMENTAL
Intervention: Home systolic BP
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Left ventricular mass index (LVMI)
Number of subjects: 97
Study: 32195950

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Acyclovir and simulated PDT treatment (control)
Number of subjects: 30
Study: 34577231

Group type: EXPERIMENTAL
Intervention: MRI simulator
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional educational method (lectures)
Number of subjects: 60
Study: 36456740

Group type: EXPERIMENTAL
Intervention: Positive pressure therapy (PPT) combined with medications, duration of 8 months.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Medications alone (Control group), n=26.
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Positive pressure therapy (PPT) combined with medications.
Number of subjects: 52
Study: 35932518

Group type: EXPERIMENTAL
Intervention: Supervised UL virtual reality exercises (ULVRE)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Non-supervised UL virtual reality exercises (ULVRE)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (conventional rehabilitation exercises)
Number of subjects: 45
Study: 35564846

Group type: EXPERIMENTAL
Intervention: Workplace-related training and case manager support
Number of subjects: 180
Study: 35096601

Group type: EXPERIMENTAL
Intervention: Core Needle Biopsy (CNB)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Fine Needle Aspiration (FNA)
Number of subjects: 84
Study: 36192552

Group type: EXPERIMENTAL
Intervention: 35 mg volagidemab
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 70 mg volagidemab
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 32556585

Group type: EXPERIMENTAL
Intervention: Unilateral laminotomy with crossover (UL)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Bilateral laminotomy (BL)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Spinous process osteotomy (SPO)
Number of subjects: 437